Stuart R. Green

Stuart R. Green

Auto-generated profile, based on publicly available information

Stuart R. Green

Structural Genomics Consortium, University of Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
MMMark F. Mabanglo
Mark F. Mabanglo
BWBrian Wilson
Brian Wilson
MNMahmoud Noureldin
Mahmoud Noureldin
SKSerah W. Kimani
Serah W. Kimani
AMAhmed Mamai
Ahmed Mamai
MVMasoud Vedadi
Masoud Vedadi
Proteolysis-targeting chimeras (PROTACs) have been explored for the degradation of drug targets for more than two decades. However, only a handful of E3 ligase substrate receptors have been efficiently used. Downregulation and mutation of these receptors would reduce the effectiveness of such PROTACs. We recently developed potent ligands for DCAF1, a substrate receptor of EDVP and CUL4 E3 ligases. Here, we focus on DCAF1 toward the development of PROTACs for WDR5, a drug target in various cancers. We report four DCAF1-based PROTACs with endogenous and exogenous WDR5 degradation effects and high-resolution crystal structures of the ternary complexes of DCAF1-PROTAC-WDR5. The structures reveal detailed insights into the interaction of DCAF1 with various WDR5-PROTACs, indicating a significant role of DCAF1 loops in providing needed surface plasticity, and reflecting the mechanism by which DCAF1 functions as a substrate receptor for E3 ligases with diverse sets of substrates.

23 June 2023 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
SKSerah W. Kimani
Serah W. Kimani
JOJulie Owen
Julie Owen
SGStuart R. Green
Stuart R. Green
FLFengling Li
Fengling Li
YLYanjun Li
Yanjun Li
LHLevon Halabelian
Levon Halabelian
DCAF1 functions as a substrate recruitment subunit for the RING-type CRL4DCAF1 and the HECT family EDVPDCAF1 E3 ubiquitin ligases. The WDR domain of DCAF1 serves as a binding platform for substrate proteins and is also targeted by HIV and SIV lentiviral adaptors to induce the ubiquitination and proteasomal degradation of antiviral host factors. It is therefore attractive both as a potential therapeutic target for the development of chemical inhibitors and as an E3 ligase that could be recruited by novel PROTACs for targeted protein degradation. In this study, we used a proteome-scale drug-target interaction prediction model, MatchMaker, combined with cheminformatics filtering and docking to identify ligands for the DCAF1 WDR domain. Biophysical screening and X-ray crystallographic studies of the predicted binders confirmed a selective ligand occupying the central cavity of the WDR domain. This study shows that artificial intelligence-enabled virtual screening methods can successfully be applied in the absence of previously known ligands.

1 March 2017 in NeuroToxicology
Verified
Journal Article
Closed access
BLBryan E. Luu
Bryan E. Luu
SGStuart R. Green
Stuart R. Green
CCChristine L. Childers
Christine L. Childers
MHMatthew R. Holahan
Matthew R. Holahan
Kenneth B StoreyKenneth B Storey
Kenneth B Storey

4 November 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
SASuzanne Ackloo
Suzanne Ackloo
FLFengling Li
Fengling Li
MSMagda Szewczyk
Magda Szewczyk
ASAlmagul Seitova
Almagul Seitova
PLPeter Loppnau
Peter Loppnau
CACheryl H. Arrowsmith
Cheryl H. Arrowsmith
Target class-focused drug discovery has a strong track record in pharmaceutical research, yet public domain data indicate that many members of protein families remain unliganded. Here we present a systematic approach to scale up the discovery and characterization of small molecule ligands for the WD40 repeat (WDR) protein family. We developed a comprehensive suite of protocols for protein production, crystallography, and biophysical, biochemical, and cellular assays. A pilot hit-finding campaign using DNA-encoded chemical library selection followed by machine learning (DEL-ML) to predict ligands from virtual libraries yielded first-in-class, drug-like ligands for 7 of the 16 WDR domains screened, thus demonstrating the broader ligandability of WDRs. This study establishes a template for evaluation of protein family wide ligandability and provides an extensive resource of WDR protein biochemical and chemical tools, knowledge, and protocols to discover potential therapeutics for this highly disease-relevant, but underexplored target class.

1 December 2016 in Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
SGStuart R. Green
Stuart R. Green
Kenneth B StoreyKenneth B Storey
Kenneth B Storey

19 September 2018 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
HHHanane Hadj‐Moussa
Hanane Hadj‐Moussa
SGStuart R. Green
Stuart R. Green
Kenneth B StoreyKenneth B Storey
Kenneth B Storey